Latest Europe News

OncoSil Medical has secured $8.7 million through a placement and share purchase plan to fund commercialization of its pancreatic cancer treatment device, aiming for positive cash flow by mid-2026. Near-completion clinical trials could soon unlock broader market access.

Ionic Rare Earths has signed a pivotal MOU with EMR to develop a circular supply chain for rare earth magnets, supporting its Belfast recycling plant and the UK’s net-zero ambitions.

Way2VAT unveils a bold growth strategy leveraging patented AI technology to dominate the expanding digital tax processing market, targeting rapid profitability in 2025. The company’s unified SaaS platform integrates VAT reclaim, real-time invoice validation, compliance services, and e-invoicing across 40+ countries.

Volt Resources Limited addresses recent media speculation about the potential cancellation of its mining licences in Guinea, confirming no formal notice has been received and engagement with authorities is underway.

Fortescue Metals Group announces a strategic leadership reshuffle, appointing Agustin 'Gus' Pichot as CEO to spearhead its green energy and decarbonisation initiatives amid evolving market dynamics.

Euro Manganese is poised to close a C$11.2 million financing round by late May, fueling progress on its strategic Chvaletice manganese project in the Czech Republic. The move underscores the company's role in Europe's battery materials supply chain.

Raiden Resources has increased its ownership in the Vuzel Gold Project from 51% to 75%, marking a key milestone driven by promising near-surface and high-grade gold discoveries. The company eyes further ownership gains as drilling continues.

Dimerix Limited’s ACTION3 Phase 3 trial for DMX-200 in treating FSGS kidney disease has passed its sixth independent safety review with no concerns, reinforcing the drug’s promising safety profile.

Altamin Limited has reported the final tranche of high-grade zinc-lead-silver assay results from its 2024 channel sampling at the Gorno Project, revealing mineralisation beyond current resource boundaries. These findings highlight new zones in previously inaccessible areas, reinforcing the project's exploration potential.

Australian Agricultural Company Limited (AACo) reported a 14% rise in operating profit to $58.4 million for FY25, driven by increased sales volumes and disciplined cost control despite challenging market conditions. The company also marked a significant reduction in statutory loss, signaling improved financial resilience.

Australian Agricultural Company Limited (AACo) reported a robust FY25 operating profit of $58.4 million, driven by increased meat and cattle sales volumes and strategic brand growth despite inflationary pressures.

AFT Pharmaceuticals reported a 6% revenue increase to NZ$208 million in FY25, driven by strong ANZ growth and expanding international presence. The company targets NZ$300 million revenue by FY27 amid ongoing R&D and new product launches.